These myeloproliferative neoplasms are characterized by hyperactivation of janus kinase 2 (JAK2)-signaling as a result of mutations in three specific genes: JAK2, calreticulin (CALR), and myeloproliferative leukemia virus (MPL). This evidence concerns the gene CALR and myeloproliferative neoplasm.